Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Multiple Myeloma 202Recurrence 53Neoplasms, Plasma Cell 19Neoplasms 12Immunoglobulin Light-chain Amyloidosis 10Hematologic Diseases 4Amyloidosis 4Renal Insufficiency 3Lymphoma, Non-Hodgkin 3Blood Protein Disorders 3Plasmacytoma 2Paraproteinemias 2Neoplasms by Histologic Type 2Disease Progression 2Chromosome 17 deletion 2Waldenstrom Macroglobulinemia 1Smoldering Multiple Myeloma 1Proteostasis Deficiencies 1Malignant Plasma Cell Neoplasms 1Lymphoma, T-Cell, Peripheral 1Leukemia, Plasma Cell 1Leukemia, Myeloid, Acute 1Hypoxia 1Hodgkin Disease 1Hematologic Neoplasms 1Disease 1Corneal Diseases 1Alzheimer Disease 1

Interventions

Lenalidomide 4Dexamethasone 4Bortezomib 3pomalidomide 2Cyclophosphamide 2ricolinostat 1Zoledronic Acid 1Vitamin D 1Transplantation, Autologous 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Calcium Dobesilate 1Calcium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Disease Progression × pomalidomide × Plasma cell × Clear all
NCT02189343 2019-11-21

Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma

Celgene

Phase 1 Completed
16 enrolled
Plasma cell

Disease, Multiple Myeloma, Recurrence, Disease Progression

NCT03601624 2018-11-14

MM-POM-2018

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

Phase 2 Unknown
18 enrolled
Plasma cell

Multiple Myeloma, Recurrence, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡